Navigation Links
Dyadic International Reports 2011 First Quarter Financial Results
Date:5/5/2011

ximately $4.2 million.

About DyadicDyadic International, Inc. is a global biotechnology company that uses its patented and proprietary technologies to conduct research, development and commercial activities for the discovery, development, manufacture and sale of enzyme and protein products for the bioenergy, industrial enzyme and biopharmaceutical industries.

Dyadic makes financial disclosures through the OTC Disclosure and News Service which offers free information on the OTC Markets website (www.otcmarkets.com) concerning companies traded on the OTC Markets. Investors can access and download Dyadic's financial reports and other announcements that Dyadic makes through the OTC Markets website. Dyadic will also continue providing updates through regular press releases as appropriate.

Cautionary Statement for Forward-Looking StatementsCertain statements contained in this press release are forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause Dyadic's actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Except as required by law, Dyadic expressly disclaims any intent or obligation to update any forward-looking statements.DYADIC INTERNATIONAL, INC. AND SUBSIDIARIESCONDENSED CONSOLIDATED STATEMENTS OF OPERATIONSThree Months Ended March 31,20112010Revenue: (Unaudited) (Unaudited) Product Related Revenue, Net

$

1,805,208

$

1,879,145License Fee Revenue-32,000Research and Development Revenue491,30988,235Total Revenue2,296,5171,999,380Cost of Goods Sold1,528,2271,605,324Gross Profit768,290394,055Expenses:General and Administrative1,684,6901,359,667Sales and Marketing 267,734226,733Research and Development 304,003286,042Foreign Currency Exchange Losses (Gains), Net(94,034)33,294Total Expenses2,162,3
'/>"/>

SOURCE Dyadic International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Two New U.S. Patents Issued to Dyadic International
2. Dyadic International to Announce 2010 Year-End Financial Results and Hold Conference Call on March 10, 2011
3. Sixth U.S. Patent Issued to Dyadic International
4. Dyadic International and EnGen Bio to Present at Rodman & Renshaw Annual Global Investment Conference
5. Dyadic International Raises Additional $1 Million to Complete $4 Million Convertible Note Offering
6. Dyadic International Reports 2010 Second Quarter Financial Results
7. Bacterin International Holdings Launches Third Biologic Scaffold
8. INC Research to Acquire Kendle International for $15.25 per Share in Cash
9. Mettler-Toledo International Inc. Announces Webcast of Presentation at Baird Growth Stock Conference
10. Onyx Pharmaceuticals Announces Carfilzomib Data Presentations at 13th International Myeloma Workshop
11. International Leaders in Electrophysiology Discuss Improving Atrial Fibrillation Treatment Using Novel Endoscopically Guided Laser Ablation Catheter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... MOUNTAIN VIEW, Calif. , July 29, 2014 ... antivirals has amplified with rising incidence rates and ... absence of a preventative vaccine. Change is underway ... and interferon regimens towards highly effective, easily-tolerated, interferon-free ... http://photos.prnewswire.com/prnh/20140728/130662 Gilead,s mega blockbuster ...
(Date:7/29/2014)... RIDGE, Colo. , July 29, 2014 /PRNewswire/ ... company focused on developing a proprietary electromagnetic induction ... it entered into an agreement under which TBC ... Continuation Investments Limited (COT) in an all-stock transaction. ... Company will initially trade on the Australian Stock ...
(Date:7/29/2014)... China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or ... in China , today announced that ... results on Tuesday, August 5, 2014 after the market ... a conference call at 8:00 a.m. ET on Wednesday, ... on August 6, 2014, to discuss second quarter 2014 ...
Breaking Medicine Technology:A Treatment Revolution is Underway: All-Oral Therapies Transform Global Hepatitis C Antiviral Market 2A Treatment Revolution is Underway: All-Oral Therapies Transform Global Hepatitis C Antiviral Market 3A Treatment Revolution is Underway: All-Oral Therapies Transform Global Hepatitis C Antiviral Market 4The BioFusionary Corporation, Inc. Announces Intent To Complete Reverse Takeover Of Australia-Based Continuation Investments Limited 2The BioFusionary Corporation, Inc. Announces Intent To Complete Reverse Takeover Of Australia-Based Continuation Investments Limited 3China Biologic to Report Second Quarter 2014 Financial Results 2China Biologic to Report Second Quarter 2014 Financial Results 3
... March 29, 2011 Royal DSM, the global ... the Ambassador of the Kingdom of the Netherlands to ... North Carolina facilities on March 28, 2011. Ambassador Jones-Bos ... and Dyneema-Ultra-High Molecular Weight Polyethylene fiber operations, and toured ...
... 2011 Diopsys, Inc. has launched the new Diopsys® ... ophthalmologists detect optic nerve disease, including glaucoma and other ... leading cause of blindness in the world, reports the ... is often called the "sneak thief of sight" because ...
Cached Medicine Technology:Dutch Ambassador Visits DSM in North Carolina 2Dutch Ambassador Visits DSM in North Carolina 3New Vision Test Helps Detect Optic Nerve Diseases Including Glaucoma 2
(Date:7/29/2014)... HealthDay Reporter , MONDAY, July 28, 2014 ... disease may be able to take hormone replacement therapy soon ... according to a new study. Previous studies, including the ... harmful effects on the heart. But, many of those women ... further past menopause. In this new study, researchers ...
(Date:7/29/2014)... Beverly Hills, CA (PRWEB) July 29, 2014 ... the world’s largest uterine fibroid was recently removed from a ... 3 hours. The woman, identified only as Latha, reportedly had ... inside her. She had been experiencing fatigue and breathlessness for ... The doctors at Kumaran Hospital in Chennai only discovered the ...
(Date:7/29/2014)... AR (PRWEB) July 29, 2014 On ... a resolution declaring the week of October 12-18, 2014, ... of case management in improving healthcare outcomes for patients. ... and Senator John Boozman (R-AR), with support by the ... Management Association to honor case management professionals for their ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 The ... named a 2014 ASAE Power of A ... public awareness campaign to encourage everyone age six months ... , ASAE recognized NFID for its power to enrich ... and action among consumers and professionals about the importance ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 Award-winning inventor Michael ... a flatulence neutralizer specifically designed to absorb embarrassing odors in ... that can easily be stored in a desk drawer. This ... the PoofPad, users will simply sit on the pad and ... at the office and then BAM, someone appears out of ...
Breaking Medicine News(10 mins):Health News:Early Hormone Therapy May Be Safe for Women's Hearts 2Health News:Early Hormone Therapy May Be Safe for Women's Hearts 3Health News:World’s Largest Uterine Fibroid Removed from Patient 2Health News:World’s Largest Uterine Fibroid Removed from Patient 3Health News:CMSA Supports National Case Management Week Resolution Introduced in US Senate 2Health News:National Foundation for Infectious Diseases Receives Top ASAE Honors for Keeping the Nation Flu-Focused 2Health News:Award-Winning Inventor Michael Croix Launches an Indiegogo Campaign for PoofPad 2Health News:Award-Winning Inventor Michael Croix Launches an Indiegogo Campaign for PoofPad 3
... issue of the Journal of Clinical Sleep Medicine ... developing obstructive sleep apnea (OSA) in adolescents but not in ... of OSA among Caucasian adolescents 12 years of age and ... mass index (BMI) z-score, while the risk of OSA did ...
... Medical Center researchers have provided the most extensive account ... patients with an extremely rare premature aging syndrome. ... of the Journal of Clinical Endocrinology and Metabolism, ... should not be lumped together with those diagnosed with ...
... , , OAK BROOK, Ill., Dec. 15 ... larger role than ever. Now the University HealthSystem Consortium (UHC) ... Achieving Cost Efficiencies in Health Care, to assist value ... with the input of value analysis staff in the field, ...
... ... help people slim down, reduce facial wrinkling, and plump lips all in one minimally ... ... fat from the abdomen and inject it into the face and lips to help ...
... , ABBOTT PARK, Ill. and HOLLYWOOD, ... ) announced today a definitive agreement to acquire STARLIMS ... of laboratory information management systems, for approximately $123 million ... position in the global diagnostics market, providing advanced web-based ...
... LOVELAND, Colo., Dec. 14 Heska Corporation (Nasdaq: ... leading provider of veterinary diagnostic and specialty products, ... Company,s new DRI-CHEM® 7000 Veterinary Chemistry Analyzer (the ... Customers receiving these analyzers have invested in the ...
Cached Medicine News:Health News:Obesity increases the risk for obstructive sleep apnea in adolescents, but not in younger children 2Health News:Researchers ID traits of people with rare accelerated aging syndrome 2Health News:University HealthSystem Consortium Offers Value Analysis Professionals Insightful New Resources 2Health News: Free Webinar Series at Aqualipo.com Shows How New Combination Liposuction/Fat Transfer Treatment Helps Patients Slim Down and Reduce Facial Wrinkling 2Health News: Free Webinar Series at Aqualipo.com Shows How New Combination Liposuction/Fat Transfer Treatment Helps Patients Slim Down and Reduce Facial Wrinkling 3Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 2Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 3Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 4Health News:Heska Announces Installation of New Chemistry Analyzer 2Health News:Heska Announces Installation of New Chemistry Analyzer 3
Used in conjunction with the E5381 600 Circling Band (40 style). Indications: When high buckle is required. Overall length: 14.0 mm....
Concave inner surface to conform to the globe. Used in conjunction with the E5381 600 Circling Band (40 style). Indications: Wide scleral bed. Outside diameter 30.2 mm....
...
...
Medicine Products: